Medindia LOGIN REGISTER
Medindia
Advertisement

Eurocor GmbH to Make Catheters for Heart Diseases

by Kathy Jones on June 2, 2013 at 3:37 PM
 Eurocor GmbH to Make Catheters for Heart Diseases

Eurocor GmbH has entered into a licensing agreement with Biosensors International Group Ltd to manufacture catheters for treating heart diseases. Eurocor is a group firm of medical technology leader Opto Circuits India Ltd.

As part of the agreement, Eurocor will manufacture three medical devices using Biosensors' drug eluting balloon (DEB) technology for treating coronary and artery diseases, while the latter will market them worldwide.

Advertisement

"The three devices are drug-eluting balloon dilatation catheters designed for percutaneous transluminal angioplasty. The first one -- BioStream has been developed for coronary arteries, BioPath for treating patients with peripheral arterial disease and BioPath 035 for peripheral intervention above knee," the company said in a statement here.

The devices will feature Eurocor's proprietary coating, delivering paclitaxel, an anti-restenotic drug, used in DEB applications.

"The innovative devices will complement our cardiac stents and facilitate our entry into the peripheral vascular disease market," Biosensors cardiovascular division president Jeffrey B. Jump said in the statement.
Advertisement

The devices will be launched in European markets and in select regions across Asia, Africa and West Asia after securing the European Conformance Marking (CE) in next six weeks.

"The agreement validates our DEB products and enables us to enter the rapidly-growing sector of the interventional devices market," Eurocor chief operating officer Antonino Laudani said.

As a vertically integrated medical technology group, the Bangalore-based Opto Circuits specialises in primary, acute and critical care devices for global markets.

Specialising in research, development and manufacture of cardiovascular and endovascular products, Eurocor provides interventional physicians with coronary stents and special cardiovascular and endovascular devices.

Source: IANS
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Corporate News

 Global Report of Work-related Diseases
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
New AI Tool Could Ensure Smooth Job Transitions
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
 Recent Improvements In Pharmaceutical Sector
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Food to be Covered by Insurance Soon
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharma Companies Have to Support or Risk Damaging Global Reputation
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Eurocor GmbH to Make Catheters for Heart Diseases Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests